Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from PYC Therapeutics Limited ( (AU:PYC) ) is now available.
PYC Therapeutics Limited has released its corporate governance statement for the financial year ending June 30, 2025, which is available on their website. The statement confirms the company’s adherence to the ASX Corporate Governance Council’s recommendations, highlighting their commitment to transparency and accountability in management and oversight.
The most recent analyst rating on (AU:PYC) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on PYC Therapeutics Limited stock, see the AU:PYC Stock Forecast page.
More about PYC Therapeutics Limited
Average Trading Volume: 635,828
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$758.2M
For a thorough assessment of PYC stock, go to TipRanks’ Stock Analysis page.